ProShares Ultra Nasdaq Biotechnology (BIB) Declined -5.05% or -2.85 To Price $53.59 On Friday


ProShares Ultra Nasdaq Biotechnology (BIB) declined -5.05% or -2.85 to $53.59. It is around 267857 shares traded, which is 129.69% compare to the average total volume 206543. The market cap of BIB is $359.05 million. The year to date change is -4.08%. The 52 week price range is from $44.62 to $69.62. Price of BIB have changed -8.32% during last week. It have changed -2.59% over last month, 2.08% over last 3 months, -5.85% over last 6 months and 14.23% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BIB is 60.58. It is 13.04% above current price. The 200-day Moving Averages for BIB is 57.14. It is 6.62% above current price. The 52-week High is 69.62. It is 29.91% from the current price. The 52-week Low is 44.62. It is -16.74% from current price.

There are some statistics of BIB. It is has market cap $359.05 million. The share outstanding is 6.70 million. The average volume is 206543. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BIB is 1.52%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BIB is -6.09%.


Tags:

Share this post